Sat, Jan 31, 2015, 4:35 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • loriskhireward loriskhireward Nov 15, 2011 12:49 PM Flag

    Recurrence is painful AND expensive, "doc"

    jiarealty, why not use Dificid as first-line treatment? you never answered this very important question...is it because you cannot, or because you possibly feel conflicted?

    I know, I know..."NAME ONE HOSPITAL OR PHYSICIAN WHO HAS ABANDONED VANCO AS FIRST-LINE TREATMENT - YOU CAN'T! YOU ARE DENSE."

    so, let's move past the fact that I am dense...and answer the question. Since you stated in previous posts you are an ID doc, why would you not use the most effective first-line treatment for your patients, when recurrences are expensive, painful, 20% likely and can result in death? good luck...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OPTR
12.780.0000(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
ImmunoGen, Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST
Amazon.com Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST